Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia
Open Access
- 15 October 2004
- journal article
- retracted article
- Published by American Society of Hematology in Blood
- Vol. 104 (8), 2492-2498
- https://doi.org/10.1182/blood-2004-03-0954
Abstract
Increasing evidence has shown that death signaling in T cells is regulated in a complicated way. Molecules other than death receptors can also trigger T-cell death. Here, we demonstrate for the first time that P-selectin glycoprotein ligand-1 (PSGL-1) or CD162 molecules cross-linked by an anti–PSGL-1 monoclonal antibody, TAB4, can trigger a death signal in activated T cells. In contrast to classic cell death, PSGL-1–mediated T-cell death is caspase independent. It involves translocation of apoptosis-inducing factor from mitochondria to nucleus and mitochondrial cytochrome c release. Ultrastructurally, both peripheral condensation of chromatin and apoptotic body were observed in PSGL-1–mediated T-cell death. Collectively, this study demonstrates a novel role for PSGL-1 in controlling activated T-cell death and, thus, advances our understanding of immune regulation.Keywords
This publication has 27 references indexed in Scilit:
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- The fundamental role of epigenetic events in cancerNature Reviews Genetics, 2002
- 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemiaBlood, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcomeBritish Journal of Haematology, 2001
- Hypermethylation of E-cadherin in leukemiaBlood, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic LeukemiaBlood, 1998
- Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhoodBlood, 1993